Literature DB >> 25841580

Integrated diagnostic strategy for the invasion depth of early gastric cancer by conventional endoscopy and EUS.

Yoshiki Tsujii1, Motohiko Kato2, Takuya Inoue1, Shunsuke Yoshii1, Kengo Nagai1, Tetsuji Fujinaga1, Akira Maekawa1, Yoshito Hayashi1, Tomofumi Akasaka3, Shinichiro Shinzaki1, Kenji Watabe1, Tsutomu Nishida4, Hideki Iijima1, Masahiko Tsujii1, Tetsuo Takehara1.   

Abstract

BACKGROUND: Although conventional endoscopy (CE) and EUS are considered useful for predicting the invasion depth (T-staging) in early gastric cancer (EGC), no effective diagnostic strategy has been established.
OBJECTIVE: To produce simple CE criteria and to elucidate an efficient diagnostic method by combining CE and EUS for accurate T-staging.
DESIGN: Single-center retrospective analysis.
SETTING: Academic university hospital. PATIENTS: Consecutive patients with EGC from April 2007 to March 2012 who underwent CE and EUS before treatment.
INTERVENTIONS: Recorded endoscopic images were independently reviewed by 3 observers. The CE criteria for massive invasion were defined, and their utility and the additional value of EUS were assessed. MAIN OUTCOME MEASUREMENTS: The accuracy of CE based on the criteria and the accuracy of EUS.
RESULTS: Two hundred thirty patients were enrolled: 195 with mucosal cancer or cancer in the submucosa less than 500 μm from the muscularis mucosae and 35 with invasive cancers. Multivariate analysis of the CE findings by 1 observer revealed that an irregular surface and a submucosal tumor-like marginal elevation were significantly associated with massive invasion. The simple CE criteria, consisting of those 2 features, had an overall accuracy of 73% to 82% and no significant differences in the diagnostic yield compared with EUS in all observers. CE accurately revealed mucosal cancer, and EUS efficiently salvaged the lesions that were over-diagnosed by CE. With our strategy, which involved the CE criteria and the optimal use of EUS, the comprehensive accuracy exceeded 85% in each observer. LIMITATIONS: Retrospective, single-center study.
CONCLUSIONS: We demonstrated a practical strategy for T-staging in EGC using simple CE criteria and EUS.
Copyright © 2015 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25841580     DOI: 10.1016/j.gie.2015.01.022

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  29 in total

1.  Model to identify early-stage gastric cancers with deep invasion of submucosa based on endoscopy and endoscopic ultrasonography findings.

Authors:  Jieyao Cheng; Xi Wu; Aiming Yang; Qingwei Jiang; Fang Yao; Yunlu Feng; Tao Guo; Weixun Zhou; Dongsheng Wu; Xuemin Yan; Yamin Lai; Jiaming Qian; Xinghua Lu; Weigang Fang
Journal:  Surg Endosc       Date:  2017-07-21       Impact factor: 4.584

2.  Risk factors associated with difficult gastric endoscopic submucosal dissection: predicting difficult ESD.

Authors:  Ji Ha Kim; Hyeong Seok Nam; Cheol Woong Choi; Dae Hwan Kang; Hyung Wook Kim; Su Bum Park; Su Jin Kim; Sun Hwi Hwang; Si Hak Lee
Journal:  Surg Endosc       Date:  2016-08-05       Impact factor: 4.584

3.  Clinical efficacy of endoscopic ultrasonography for decision of treatment strategy of gastric cancer.

Authors:  Jung Kim; Sang Gyun Kim; Hyunsoo Chung; Joo Hyun Lim; Ji Min Choi; Jae Yong Park; Hyo-Joon Yang; Seung Jun Han; Sooyeon Oh; Min Seong Kim; Hyun Ju Kim; Hyoungju Hong; Hee Jong Lee; Jue Lie Kim; Eunwoo Lee; Hyun Chae Jung
Journal:  Surg Endosc       Date:  2018-02-12       Impact factor: 4.584

4.  Endoscopic ultrasound in gastric cancer staging before and after neoadjuvant chemotherapy. A comparison with PET-CT in a clinical series.

Authors:  Eduardo Redondo-Cerezo; Juan Gabriel Martínez-Cara; Rita Jiménez-Rosales; Francisco Valverde-López; Antonio Caballero-Mateos; Pablo Jérvez-Puente; Jose Luis Ariza-Fernández; Margarita Úbeda-Muñoz; Mercedes López-de-Hierro; Javier de Teresa
Journal:  United European Gastroenterol J       Date:  2016-12-12       Impact factor: 4.623

5.  A specific role of endoscopic ultrasonography for therapeutic decision-making in patients with gastric cardia cancer.

Authors:  Chan Hyuk Park; Jun Chul Park; Hyunsoo Chung; Sung Kwan Shin; Sang Kil Lee; Yong Chan Lee
Journal:  Surg Endosc       Date:  2015-12-29       Impact factor: 4.584

6.  Preoperative predictors of beyond endoscopic submucosal dissection indication or lymphovascular invasion in endoscopic resection for early gastric cancer.

Authors:  Su Jin Kim; Cheol Woong Choi; Dae Hwan Kang; Hyung Wook Kim; Su Bum Park; Hyeong Seok Nam; Dae Gon Ryu
Journal:  Surg Endosc       Date:  2017-12-26       Impact factor: 4.584

7.  Clinical significance of endoscopic ultrasonography in diagnosing invasion depth of early gastric cancer prior to endoscopic submucosal dissection.

Authors:  Kazutaka Kuroki; Shiro Oka; Shinji Tanaka; Naoki Yorita; Kosaku Hata; Takahiro Kotachi; Tomoyuki Boda; Koji Arihiro; Kazuaki Chayama
Journal:  Gastric Cancer       Date:  2020-06-22       Impact factor: 7.370

8.  What types of early gastric cancer are indicated for endoscopic ultrasonography staging of invasion depth?

Authors:  Jiro Watari; Shigemitsu Ueyama; Toshihiko Tomita; Hisatomo Ikehara; Kazutoshi Hori; Ken Hara; Takahisa Yamasaki; Takuya Okugawa; Takashi Kondo; Tomoaki Kono; Katsuyuki Tozawa; Tadayuki Oshima; Hirokazu Fukui; Hiroto Miwa
Journal:  World J Gastrointest Endosc       Date:  2016-08-25

9.  Hierarchical Analysis of Factors Associated with T Staging of Gastric Cancer by Endoscopic Ultrasound.

Authors:  Jung Kim; Hyunsoo Chung; Jue Lie Kim; Eunwoo Lee; Sang Gyun Kim
Journal:  Dig Dis Sci       Date:  2020-03-17       Impact factor: 3.199

10.  Morphologic pattern analysis of submucosal deformities identified by endoscopic ultrasonography for predicting the depth of invasion in early gastric cancer.

Authors:  Tae Young Kim; Nam Hee Yi; Jin Won Hwang; Ji Hyun Kim; Gwang Ha Kim; Mi Seon Kang
Journal:  Surg Endosc       Date:  2018-10-17       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.